HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print February 13, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.1203638v1 75/5/884    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, G. K. Articles by Kaminski, N. E. Search for Related Content PubMed PubMed Citation Articles by Rao, G. K. Articles by Kaminski, N. E.

(Journal of Leukocyte Biology. 2004;75:884-892.)
© 2004 by Society for Leukocyte Biology

Cannabinoid receptor-mediated regulation of intracellular calcium by ⁹-tetrahydrocannabinol in resting T cells

Gautham K. Rao^*,,, Wei Zhang^*, and Norbert E. Kaminski^*,,,1

^* Department of Pharmacology and Toxicology,
National Food Safety and Toxicology Center, and
Center for Integrative Toxicology, Michigan State University, East Lansing

¹Correspondence: Department of Pharmacology and Toxicology, 315 National Food Safety and Toxicology Center, Michigan State University, East Lansing, MI 48824. E-mail: kamins11{at}msu.edu

Cannabinoids exhibit broad immune modulating activity by targeting many cell types within the immune system, including T cells, which exhibit sensitivity, as evidenced by altered activation, proliferation, and cytokine expression. As a result of the critical role calcium plays in T cell function coupled with previous findings demonstrating disruption of the calcium-regulated transcription factor, nuclear factor of activated T cells, by cannabinoid treatment, the objective of the present investigation was to perform an initial characterization of the role of the cannabinoid receptors in the regulation of the intracellular calcium concentration ([Ca²⁺]_i) by ⁹-tetrahydrocannabinol (⁹-THC) in T lymphocytes. Here, we demonstrate that ⁹-THC robustly elevates [Ca²⁺]_i in purified murine splenic T cells and in the human peripheral blood acute lymphoid leukemia (HPB-ALL) human T cell line but only minimally elevates [Ca²⁺]_i in Jurkat E6-1 (dysfunctional cannabinoid receptor 2-expressing) human T cells. Removal of extracellular calcium severely attenuated the ⁹-THC-mediated rise in [Ca²⁺]_i in murine splenic T cells and HPB-ALL cells. Pretreatment with cannabinoid receptor antagonists, SR144528 and/or SR141716A, led to an attenuation of ⁹-THC-mediated elevation in [Ca²⁺]_i in splenic T cells and HPB-ALL cells but not in Jurkat E6-1 cells. Furthermore, pretreatment of HPB-ALL cells with SR144528 antagonized the small rise in [Ca²⁺]_i elicited by ⁹-THC in the absence of extracellular calcium. These findings suggest that ⁹-THC induces an influx of extracellular calcium in resting T cells in a cannabinoid receptor-dependent manner.

Key Words: immune system • CB2 • CP55, 940 • CB1 • SR141716A • SR144528

This article has been cited by other articles:

				E. D. Giudice, L. Rinaldi, M. Passarotto, F. Facchinetti, A. D'Arrigo, A. Guiotto, M. D. Carbonare, L. Battistin, and A. Leon Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells J. Leukoc. Biol., June 1, 2007; 81(6): 1512 - 1522. [Abstract] [Full Text] [PDF]

				S. Raduner, A. Majewska, J.-Z. Chen, X.-Q. Xie, J. Hamon, B. Faller, K.-H. Altmann, and J. Gertsch Alkylamides from Echinacea Are a New Class of Cannabinomimetics: CANNABINOID TYPE 2 RECEPTOR-DEPENDENT AND -INDEPENDENT IMMUNOMODULATORY EFFECTS J. Biol. Chem., May 19, 2006; 281(20): 14192 - 14206. [Abstract] [Full Text] [PDF]

				G. K. Rao and N. E. Kaminski Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 820 - 829. [Abstract] [Full Text] [PDF]

				G. K. Rao and N. E. Kaminski Induction of intracellular calcium elevation by {Delta}9-tetrahydrocannabinol in T cells involves TRPC1 channels J. Leukoc. Biol., January 1, 2006; 79(1): 202 - 213. [Abstract] [Full Text] [PDF]

				J. C. Sipe, N. Arbour, A. Gerber, and E. Beutler Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders J. Leukoc. Biol., July 1, 2005; 78(1): 231 - 238. [Abstract] [Full Text] [PDF]

				B. L. F. Kaplan, Y. Ouyang, C. E. Rockwell, G. K. Rao, and N. E. Kaminski 2-Arachidonoyl-glycerol suppresses interferon-{gamma} production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2 J. Leukoc. Biol., June 1, 2005; 77(6): 966 - 974. [Abstract] [Full Text] [PDF]

				S. R. Kim, D. Y. Lee, E. S. Chung, U. T. Oh, S. U. Kim, and B. K. Jin Transient Receptor Potential Vanilloid Subtype 1 Mediates Cell Death of Mesencephalic Dopaminergic Neurons In Vivo and In Vitro J. Neurosci., January 19, 2005; 25(3): 662 - 671. [Abstract] [Full Text] [PDF]